Genotype-phenotype correlations of mutations and polymorphisms in HSD11B2, the gene encoding the kidney isozyme of 11β-hydroxysteroid dehydrogenase

被引:22
作者
White, PC [1 ]
Agarwal, AK
Nunez, BS
Giacchetti, G
Mantero, F
Stewart, PM
机构
[1] Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA
[2] Univ Ancona, Azienda Osped Umberto 1, Div Endocrinol, I-60100 Ancona, Italy
[3] Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England
关键词
D O I
10.3109/07435800009048598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mutations in the HSD11B2 gene encoding the kidney (11-HSD2) isozyme of 11 beta -hydroxysteroid dehydrogenase cause the syndrome of apparent mineralocorticoid excess, a form of salt-sensitive hypertension. Enzymatic activities of mutant enzymes measured in cultured cells are correlated with several parameters of clinical severity including urinary steroid product:precursor ratios, age at diagnosis, birth weight and potassium levels, but not with blood pressure. In normals or in subjects with essential hypertension, sensitivity of blood pressure to salt loading is correlated with activity of renal 11-HSD2, as measured by an increase in the ratio of urinary free cortisol/urinary free cortisone UFF/UFE), and also correlated with length of a CA repeat polymorphism in the first intron of HSD 11B2. A functional explanation for these associations remains to be elucidated.
引用
收藏
页码:771 / 780
页数:10
相关论文
共 7 条
[1]   EXPRESSION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE USING RECOMBINANT VACCINIA VIRUS [J].
AGARWAL, AK ;
TUSIELUNA, MT ;
MONDER, C ;
WHITE, PC .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (12) :1827-1832
[2]  
AGARWAL AK, 2000, IN PRESS HYPERTENSIO
[3]   Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess [J].
Li, A ;
Tedde, R ;
Krozowski, ZS ;
Pala, A ;
Li, KXZ ;
Shackleton, CHL ;
Mantero, F ;
Palermo, M ;
Stewart, PM .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (02) :370-379
[4]   Molecular basis of human salt sensitivity:: The role of the 11β-hydroxysteroid dehydrogenase type 2 [J].
Lovati, E ;
Ferrari, P ;
Dick, B ;
Jostarndt, K ;
Frey, BM ;
Frey, FJ ;
Schorr, U ;
Sharma, AM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) :3745-3749
[5]   Mutants of 11β-hydroxysteroid dehydrogenase (11-HSD2) with partial activity -: Improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess [J].
Nunez, BS ;
Rogerson, FM ;
Mune, T ;
Igarashi, Y ;
Nakagawa, Y ;
Phillipov, G ;
Moudgil, A ;
Travis, LB ;
Palermo, M ;
Shackleton, C ;
White, PC .
HYPERTENSION, 1999, 34 (04) :638-642
[6]   11 beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess [J].
White, PC ;
Mune, T ;
Agarwal, AK .
ENDOCRINE REVIEWS, 1997, 18 (01) :135-156
[7]   A genetic defect resulting in mild low-renin hypertension [J].
Wilson, RC ;
Dave-Sharma, S ;
Wei, JQ ;
Obeyesekere, VR ;
Li, K ;
Ferrari, P ;
Krozowski, ZS ;
Shackleton, CHL ;
Bradlow, L ;
Wiens, T ;
New, MI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :10200-10205